INTRODUCTION
Abdominal infections in patients with neutropenia are usually severe and life-threatening. 1 Neutropenia may be due to a primary hematologic disorder or secondary to chemotherapy. The frequency of acute cholecystitis in this population is between 0.4-1.65% with a 30-day mortality of 26-48%, 2 being acalculous cholecystitis the most common presentation. 3, 4 Neutropenic enterocolitis is the most common intra abdominal infections associated with fever in neutropenic patients. 5, 6 However, acute cholecystitis may have an atypical presentation in this patients and should always be considered as a differential diagnosis. 7, 8 Unfortunately there is scarce information on this topic on the literature and as a result there are no specific recommendations to guide diagnosis and treatment of acute cholecystitis in hematologic diseases. The aim of this study was to describe the clinical characteristics, diagnostic approach, treatment, and outcomes of patients with hematological disorders, specifically neutropenia and fever associated with acute cholecystitis in a tertiary referral hospital.
PATIENTS AND METHODS
A search was performed at our institution's electronic system to identify patients admitted to the hospital with the diagnosis of neutropenia and fever between January 2000 and January 2017. We included patients with diagnosis of acute cholecystitis. Neutropenia was defined according to the American Society of Hematology as an absolute neutrophil count below 1,500 cells/l. 9 Diagnosis and severity of acute cholecystitis were established based on the Tokyo guidelines. 10, 11 Quantitative variables were described with mean and standard deviation and qualitative variables with absolute frequencies and percentages.
RESULTS

General characteristics
Out of 2,007 patients hospitalized for neutropenia and fever 12 cases (0.59%) were associated with acute cholecystitis ( Table 1 
Treatment
Initially all patients received broad spectrum antibiotics, including carbapenems and vancomycin in most cases, as shown in Table 1 
DISCUSSION
Abdominal pain in patients with neutropenia might require an exhaustive approach due to its broad differential diagnosis and atypical presentation among these patients, 12 who may not present an inflammatory response. Despite neutropenic enterocolitis being the most common etiology in this scenario, 13 acute cholecystitis should be considered as a differential diagnosis. 14 It is thought that the smaller mucosal surface of the gallbladder compared with the colon might explain the low frequency of acute cholecystitis as etiology of abdominal pain in neutropenic patients with fever. 1 Our study showed a frequency of 0.59% without male or female predominance, similar to the reported in other series. 15 Acalculous cholecystitis was documented in 50% of the cases, compared to 55-65% in other series. 16 In non-neutropenic patients acalculous cholecystitis is much less frequent, comprising roughly 5% of the cases of acute cholecystitis. This may be because patients with neutropenia have several risk factors for this presentation such as bile stasis, prolonged fasting, and increased intraluminal pressure. 11 however, there is not enough evidence to recommend one procedure over the other in this specific population. All our patients met Tokyo criteria for acute cholecystitis, and 11 patients (91%) were classified as severe based on hematological failure resulting either from their underlying disease or from chemotherapy induced myelosuppression, but probably not because of severe sepsis, which questions the validity of these criteria in this specific population. As a matter of fact, hematologic failure was the only criteria of severity in 5 of 11 patients. Hematologic disease is an important factor to consider when planning treatment because most patients will need transfusion of blood products prior to any invasive procedure. In our study ten patients (83.3%) required blood products including platelets transfusion in 8 patients (88.8%), fresh frozen plasma in 1 patient (11.1%)
and red blood cells transfusion in 1 patients (11.1%).
Concerning treatment (Table 3) , cholecystostomy was performed in 9 patients (75%), laparoscopic cholecystectomy in 2 (16.6%), and one patient received only medical treatment. Mortality in our series was 33.3%, which is in line with the 26-48% reported in previous studies. 17 Septic shock was the main cause of death. There were no deaths in the laparoscopic cholecystectomy group, while three patients in the cholecystostomy group (37%), and one in the antibiotic treatment group died. According to these results, surgical cholecystectomy or percutaneous cholecystostomy may be more beneficial than antibiotic treatment alone. Mortality was higher in acalculous presentation when compared to calculous cholecystitis (50% versus 16.6%, respectively) probably explained by the fact that the former represents a group of patients with a more severe disease or with a delayed diagnosis.
In conclusion, acute cholecystitis in neutropenic patients is a rare diagnosis, accounting for less than 1% of the neutropenic fever admissions. Among this group of patients, acalculous cholecystitis is more frequent than in general population. Blood and bile cultures should be ob- 
